 |
 |
|
|
|
| Leuprorelin Acetate |
 |
| C59H84N16O12 |
 |
| 53714-56-0 |
 |
It is clinically used to treat endometriosis, hysteromyoma accompanied with menorrhagia, lower abdominal pain, low back pain and anaemia, etc.
the positive patients with pre-menopause breast carcinoma and estrogen receptor
carcinoma of prostate and central sexual precocity |
 |
Parameters of Product:
1 .Appearance :White powder
2 .Specific Optical Rotation D(c=1,1%HAc) :-38.0~-42.0¡Æ
3 .Water Content(Karl Fischer) :¡Â5.0%
4 .Acetate Content(by HPLC) :¡Â12.0%
5 .Amino Acid Composition :¡¾10% of theoretical
6 .Purity (by HPLC) :¡Ã98.0%
7 .Single Impurity(by HPLC) :¡Â1.0%
8 .Peptide Content(by N%) :¡Ã80%
9 .Assay(By Anhydrous, Acetic Acid-free ) :97.0~103.0%
10 .Bacterial Endotoxins :¡Â5EU/mg
|
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
